Kabuki Syndrome Foundation launches Kabuki INSIGHTS registry

The Kabuki Syndrome Foundation on Oct. 1 launched Kabuki INSIGHTS, a patient-powered research registry designed to help researchers better understand Kabuki syndrome and prepare for future clinical trials and treatments. The platform collects survey data and optional electronic health records to build real-world evidence across the lifespan.

Why it matters: - Kabuki INSIGHTS is meant to fill a major data gap in a rare disease where long-term, real-world evidence is limited. - The registry is designed to help researchers identify unmet needs, improve clinical trial readiness, and support future treatment development for Kabuki syndrome. - Families and people living with Kabuki syndrome can contribute directly to the research base through the platform.

What happened: - The Kabuki Syndrome Foundation launched Kabuki INSIGHTS on Oct. 1, 2026. - Kabuki INSIGHTS stands for Integrated registry Study for Insights into Genetics, Health & Therapeutic Strategies in Kabuki syndrome. - The platform is a patient-powered research registry for Kabuki syndrome. - The registry collects information through online surveys and, optionally, electronic health records. - More information is available on the Kabuki Syndrome Foundation’s website: More information

The details: - Kabuki INSIGHTS is designed to bring together lived experience and clinical information to generate real-world evidence. - The registry aims to help researchers better understand Kabuki syndrome, identify unmet needs, and strengthen future clinical trials. - Data collected over time is intended to build a picture of Kabuki syndrome across childhood, adolescence, and adulthood. - The registry opened to enrollment on Oct. 1, 2026. - Patrick Dunbar, executive director of the Kabuki Syndrome Foundation, said the platform is rooted in the belief that family experiences can help move the community forward. - Dr. Clara Tang, chief scientific officer at the Kabuki Syndrome Foundation, said researchers and regulatory agencies need robust real-world data to understand the condition across the lifespan. - Dr. Margaret P. Adam, a clinical geneticist at Seattle Children’s Hospital and the University of Washington, said registries help providers and researchers learn from a large community over time. - Jeff Trotter, principal at J Trotter Research & Consulting, said well-governed patient registries are essential for scientifically valid real-world evidence in rare disease.

Between the lines: - The launch extends the foundation’s role from research funder to research infrastructure builder. - A centralized registry can make it easier to recruit for studies, compare outcomes, and track changes in a rare disease where patients are scattered geographically. - The steering committee structure suggests an effort to balance scientific rigor, community input, and industry relevance. - The registry’s optional electronic health record component could deepen the dataset beyond survey responses alone.

What's next: - The registry will grow as more individuals and families enroll and contribute data over time. - KSF expects the platform to support future research priorities, clinical trial planning, and treatment development. - The broader goal is to build a research-ready dataset that can help accelerate scientific discovery and future therapies.

The bottom line: - Kabuki INSIGHTS gives the Kabuki syndrome community a new way to turn everyday experience into research data that could shape the next generation of studies and treatments.